Neurava, a startup that creates cutting-edge wearable technology, has secures $2.26 million in seed funding. Lead by Life Science Angels, the round also featured assistance from Purdue Innovates, Elevate Ventures, Rivermount Ventures, and First Leaf Capital, as well as a second strategic investment from UCB.
CTO Vivek Ganesh said: “This funding will allow us to complete a pivotal usability study at leading clinical institutions in adults and pediatric patients with epilepsy. We will also set up manufacturing partners and submit for FDA clearance, in advance of our Series A round of funding.”
Neurava is a MedTech startup co-founded by CEO Jay Shah and CTO Vivek Ganesh. The company makes smart wearables that can detect and warn for seizure, cardiorespiratory failure, and imminent SUDEP risk. The world’s epileptic population may benefit from this diagnostic platform in ways that could save lives.
Read also – CA-based Float Health Secures $10Million in Series A Round Funding
About Neurava
A medical device firm called Neurava is developing the first-ever smart wearable that can recognise and warn of seizures and imminent SUDEP danger based on the identification of a possible mechanism of action behind Sudden Unexpected Death in Epilepsy (SUDEP).
The company’s scientific founders invented a diagnostic platform that might potentially save the lives of the 50 million individuals with epilepsy worldwide and the estimated 3.5 million persons with epilepsy in the United States.
